Indexes of von Willebrand Factor as Biomarkers of Aortic Stenosis Severity (from the Biomarkers of Aortic Stenosis Severity [BASS] Study)

被引:41
作者
Blackshear, Joseph L. [1 ]
Wysokinska, Ewa M. [2 ]
Safford, Robert E. [1 ]
Thomas, Colleen S. [3 ]
Stark, Mark E. [4 ]
Shapiro, Brian P. [1 ]
Ung, Steven [1 ]
Johns, Gretchen S. [5 ]
Chen, Dong [6 ]
机构
[1] Mayo Clin Florida, Div Cardiovasc Dis, Jacksonville, FL 32224 USA
[2] Mayo Clin, Div Hematol, Rochester, MN USA
[3] Mayo Clin Florida, Biostat Unit, Jacksonville, FL USA
[4] Mayo Clin Florida, Div Gastroenterol & Hepatol, Jacksonville, FL USA
[5] Mayo Clin Florida, Dept Lab Med & Pathol, Jacksonville, FL USA
[6] Mayo Clin, Div Hematopathol, Rochester, MN USA
关键词
ECHOCARDIOGRAPHIC-ASSESSMENT; DISEASE; FLOW; CARDIOMYOPATHY; MANAGEMENT; DIAGNOSIS; IMPACT;
D O I
10.1016/j.amjcard.2012.10.015
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We correlated von Willebrand factor (VWF) activity indexes and brain natriuretic peptide (BNP) with measures of aortic stenosis (AS) severity, bleeding, symptoms, and freedom from death or aortic valve replacement. Patients with AS (n = 66 [16 mild, 20 moderate, and 30 severe]) and aortic valve replacement (n = 21) were assessed with VWF antigen, VWF latex agglutination immunoturbidic activity, platelet function analyzer collagen plus adenosine diphosphate (PFA-CADP), VWF multimer ratio, and BNP level after echocardiography. In patients with AS, the mean gradient correlated with BNP (Spearman r = 0.29, p = 0.02), VWF latex agglutination immunoturbidic activity/VWF antigen ratio (r = -0.41, p<0.001), PFA-CADP (r = 0.49, p<0.001), and VWF multimer ratio (r = -0.76, p<0.001). The area under the curve for detection of severe AS was 0.62 (95% confidence interval [CI] 0.48 to 0.77) by elevated BNP, 0.81 (95% CI 0.69 to 0.92) by PFA-CADP closure time, 0.69 (95% CI 0.55 to 0.82) by VWF latex agglutination immunoturbidic activity/VWF antigen ratio, and 0.86 (95% CI 0.76 to 0.95) by VWF multimer ratio. For the VWF multimer ratio, a threshold of 0.15 yielded a sensitivity and specificity for severe AS of 77% and positive predictive value of 74%. Bleeding (in 14%) was associated with a prolonged PFA-CADP time and reduced VWF latex agglutination immunoturbidic activity/VWF antigen ratio. Symptoms were associated with elevated BNP and low Duke Activity Status Index score. In 66 patients with AS, freedom from death (n = 4) or aortic valve replacement (n = 22) was associated with PFA-CADP (p = 0.003), VWF high-molecular/weight multimers (p = 0.009), and VWF latex agglutination immunoturbidic activity/VWF antigen ratio (p<0.001) but not BNP (p = 0.32). In severe AS versus aortic valve replacement, the PFA-CADP and VWF multimer ratio differed (p<0.001), but BNP and the VWF latex agglutination inununoturbidic activity/VWF antigen ratio did not. In conclusion, the VWF activity indexes were associated with AS severity and bleeding and were predictive of cardiovascular outcomes. (C) 2013 Elsevier Inc. All rights reserved. (Am J Cardiol 2013;111:374-381)
引用
收藏
页码:374 / 381
页数:8
相关论文
共 30 条
[21]   Plasma von Willebrand factor multimer quantitative analysis by in-gel immunostaining and infrared fluorescent imaging [J].
Pruthi, Rajiv K. ;
Daniels, Todd M. ;
Heit, John A. ;
Chen, Dong ;
Owen, Whyte G. ;
Nichols, William L. .
THROMBOSIS RESEARCH, 2010, 126 (06) :543-549
[22]   Acquired type 2A von Willebrand syndrome caused by aortic valve disease corrects during valve surgery [J].
Solomon, C. ;
Budde, U. ;
Schneppenheim, S. ;
Czaja, E. ;
Hagl, C. ;
Schoechl, H. ;
von Depka, M. ;
Rahe-Meyer, N. .
BRITISH JOURNAL OF ANAESTHESIA, 2011, 106 (04) :494-500
[23]   Natriuretic Peptides in Common Valvular Heart Disease [J].
Steadman, Christopher D. ;
Ray, Simon ;
Ng, Leong L. ;
McCann, Gerry P. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (19) :2034-2048
[24]  
Sucker C, 2005, THROMB HAEMOSTASIS, V94, P465
[25]   Diagnostic workup of patients with acquired von Willebrand syndrome: a retrospective single-centre cohort study [J].
Tiede, A. ;
Priesack, J. ;
Werwitzke, S. ;
Bohlmann, K. ;
Oortwijn, B. ;
Lenting, P. ;
Eisert, R. ;
Ganser, A. ;
Budde, U. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2008, 6 (04) :569-576
[26]   Risk stratification of patients with aortic stenosis [J].
Vahanian, Alec ;
Otto, Catherine M. .
EUROPEAN HEART JOURNAL, 2010, 31 (04) :416-423
[27]   Acquired von Willebrand syndrome in aortic stenosis [J].
Vincentelli, A ;
Susen, S ;
Le Tourneau, T ;
Six, I ;
Fabre, O ;
Juthier, F ;
Bauters, A ;
Decoene, C ;
Goudemand, J ;
Prat, A ;
Jude, B .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (04) :343-349
[28]   Gastrointestinal bleeding, angiodysplasia, cardiovascular disease, and acquired von Willebrand syndrome [J].
Warkentin, TE ;
Moore, JC ;
Anand, SS ;
Lonn, EM ;
Morgan, DG .
TRANSFUSION MEDICINE REVIEWS, 2003, 17 (04) :272-286
[29]   Acquired and reversible von Willebrand disease with high shear stress aortic valve stenosis [J].
Yoshida, K ;
Tobe, S ;
Kawata, M ;
Yamaguchi, M .
ANNALS OF THORACIC SURGERY, 2006, 81 (02) :490-494
[30]   Low-Gradient "Severe" Aortic Stenosis With Normal Systolic Function Time to Refine the Guidelines? [J].
Zoghbi, William A. .
CIRCULATION, 2011, 123 (08) :838-840